⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11179593 | 1.00 | — | — | |
| SCHEMBL27608830 | 0.82 | ALDH1A1 (0.56) | — | |
| SCHEMBL1168252 | 0.80 | — | — | |
| SCHEMBL9295642 | 0.78 | — | — | |
| SCHEMBL3500621 | 0.76 | — | — | |
| SCHEMBL10886193 | 0.76 | — | — | |
| SCHEMBL25859790 | 0.76 | — | — | |
| SCHEMBL3347031 | 0.76 | — | — | |
| SCHEMBL11198641 | 0.76 | ALDH1A1 (0.63) | — | |
| SCHEMBL3138606 | 0.74 | ALDH1A1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2442 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12494072-B2 | Maturity classification of stained reticulocytes using optical microscopy | Siemens Healthineers Ag (DE) | 2025-12-09 | — | — | US | claimed |
| CN-120202201-A | Inhibitors of ubiquitin-specific protease 1 and uses thereof | 深圳晶泰科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119454995-A | Multifunctional nano-carrier with drug resistance, biotin receptor targeting and low-oxygen/low-pH dual responsiveness as well as preparation method and application thereof | 北京工业大学 | 2025-02-18 | — | — | CN | claimed |
| CN-117486761-A | Aryl-containing chloroethyl nitrosourea compound and preparation method and application thereof | 南方医科大学 | 2024-02-02 | — | — | CN | claimed |
| EP-4276112-A1 | ANTI-FGFR3 ANTIBODY AND USE THEREOF | AIMED BIO INC. (KR) | 2023-11-15 | — | — | EP | claimed |
| CN-116870172-A | Folic acid modified drug-resistant hypoxia activated nano-carrier and preparation method and application thereof | 北京工业大学 | 2023-10-13 | — | — | CN | claimed |
| CN-115811990-A | Novel nucleolin binding peptides and uses thereof | 安尼根有限公司 | 2023-03-17 | — | — | CN | claimed |
| EP-3978902-B1 | MATURITY CLASSIFICATION OF STAINED RETICULOCYTES USING OPTICAL MICROSCOPY | SIEMENS HEALTHCARE GMBH (DE) | 2023-02-22 | — | — | EP | claimed |
| CN-109071622-B | Peptides with anticancer activity | IDP研发制药有限公司（ES） | 2023-01-13 | — | — | CN | claimed |
| CN-111467500-B | Low-oxygen dual-targeting AGT inhibitor conjugate and preparation method and application thereof | 北京工业大学 | 2022-08-09 | — | — | CN | claimed |
| WO-1998052944-A1 | HETEROARYLCARBOXAMIDE COMPOUNDS ACTIVE AGAINST PROTEIN TYROSINE KINASE RELATED DISORDERS | SUGEN, INC. (US) | 1998-11-26 | — | — | WO | claimed |
| US-5691307-A | ANTITUMOR AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-11-25 | — | — | US | claimed |
| EP-0758249-A1 | PROGRAMMABLE GENOTOXIC AGENTS AND USES THEREFOR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1997-02-19 | — | — | EP | claimed |
| EP-0523100-B1 | O6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | US HEALTH (US) | 1996-08-28 | — | — | EP | claimed |
| WO-1995030442-A1 | PROGRAMMABLE GENOTOXIC AGENTS AND USES THEREFOR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1995-11-16 | — | — | WO | claimed |
| EP-0668782-A1 | COMBINATION OF ANTINEOPLASTIC AGENT AND ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1995-08-30 | — | — | EP | claimed |
| US-5358952-A | Anticarcinogenic agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-25 | — | — | US | claimed |
| WO-1994008625-A1 | COMBINATION OF ANTINEOPLASTIC AGENT AND ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1994-04-28 | — | — | WO | claimed |
| WO-1989005138-A1 | METHOD OF FORMING BIOERODIBLE IMPLANTS FOR IMPROVED CONTROLLED DRUG RELEASE | CHASIN MARK (US) | 1989-06-15 | — | — | WO | claimed |
| EP-0074103-B1 | N-(N'-(2-CHLOROETHYL)-N'-NITROSO-CARBAMOYL)-OLIGOPEPTIDE ESTERS AND AMIDES, AND PROCESS FOR PREPARING THEM | Eisenbrand, Gerhard, Prof. Dr. (DE) | 1986-01-29 | — | — | EP | claimed |